Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Liqin Du, Robert Borkowski, Zhenze Zhao, Xiuye Ma, Xiaojie Yu, Xian-Jin Xie & Alexander Pertsemlidis. (2013) A high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel. RNA Biology 10:11, pages 1700-1713.
Read now
Read now
Prithviraj Bose, Gary L Simmons & Steven Grant. (2013) Cyclin-dependent kinase inhibitor therapy for hematologic malignancies. Expert Opinion on Investigational Drugs 22:6, pages 723-738.
Read now
Read now
Bing Song, X. Shawn Liu, Korbin Davis & Xiaoqi Liu. (2011) Plk1 Phosphorylation of Orc2 Promotes DNA Replication under Conditions of Stress. Molecular and Cellular Biology 31:23, pages 4844-4856.
Read now
Read now
Neil Johnson & Geoffrey I Shapiro. (2010) Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors. Expert Opinion on Therapeutic Targets 14:11, pages 1199-1212.
Read now
Read now
Robert C Jackson, Anna L Barnett, Steven J McClue & Simon R Green. (2008) Seliciclib, a cell-cycle modulator that acts through the inhibition of cyclin-dependent kinases. Expert Opinion on Drug Discovery 3:1, pages 131-143.
Read now
Read now
Emmy W. Verschuren, Kenneth H. Ban, Marilyn A. Masek, Norman L. Lehman & Peter K. Jackson. (2007) Loss of Emi1-Dependent Anaphase-Promoting Complex/Cyclosome Inhibition Deregulates E2F Target Expression and Elicits DNA Damage-Induced Senescence. Molecular and Cellular Biology 27:22, pages 7955-7965.
Read now
Read now
Vincent Archambault, Amy E. Ikui, Benjamin J. Drapkin & Frederick R. Cross. (2005) Disruption of Mechanisms That Prevent Rereplication Triggers a DNA Damage Response. Molecular and Cellular Biology 25:15, pages 6707-6721.
Read now
Read now
Peter M Fischer & Athos Gianella-Borradori. (2005) Recent progress in the discovery and development of cyclin-dependent kinase inhibitors. Expert Opinion on Investigational Drugs 14:4, pages 457-477.
Read now
Read now
Articles from other publishers (36)
Lin Li, Xiaoyan Hu, Jewel Nkwocha, Kanika Sharma, Maciej Kmieciak, Hashim Mann, Liang Zhou & Steven Grant. (2023) Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells. Cellular Oncology.
Crossref
Crossref
Ahmed Abdul Kareem Najm, Ahmad Azfaralariff, Herryawan Ryadi Eziwar Dyari, Babul Airianah Othman, Muhammad Shahid, Nahid Khalili, Douglas Law, Sharifah Sakinah Syed Alwi & Shazrul Fazry. (2021) Anti-breast cancer synthetic peptides derived from the Anabas testudineus skin mucus fractions. Scientific Reports 11:1.
Crossref
Crossref
Zhen Shu, Zhen Li, Huanhuan Huang, Yan Chen, Jun Fan, Li Yu, Zhihui Wu, Ling Tian, Qi Qi, Shuang Peng, Changyong Wei, Zhongqiu Xie, Xiaobo Li, Qi Feng, Hao Sheng, Guangqiang Li, Dongping Wei, Changliang Shan & Guo Chen. (2020) Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition. Oncogene 39:35, pages 5721-5733.
Crossref
Crossref
Maryam Masnadi-Shirazi, Mano R. Maurya, Gerald Pao, Eugene Ke, Inder M. Verma & Shankar Subramaniam. (2019) Time varying causal network reconstruction of a mouse cell cycle. BMC Bioinformatics 20:1.
Crossref
Crossref
Paige M. Chorner & Roger A. Moorehead. (2018) A-674563, a putative AKT1 inhibitor that also suppresses CDK2 activity, inhibits human NSCLC cell growth more effectively than the pan-AKT inhibitor, MK-2206. PLOS ONE 13:2, pages e0193344.
Crossref
Crossref
Fatemeh Alikarami, Majid Safa, Mohammad Faranoush, Parisa Hayat & Ahmad Kazemi. (2017) Inhibition of DNA-PK enhances chemosensitivity of B-cell precursor acute lymphoblastic leukemia cells to doxorubicin. Biomedicine & Pharmacotherapy 94, pages 1077-1093.
Crossref
Crossref
Leire Neri, Marta Lasa, Alberto Elosegui-Artola, Delia D'Avola, Beatriz Carte, Cristina Gazquez, Sara Alve, Pere Roca-Cusachs, Mercedes Iñarrairaegui, Jose Herrero, Jesús Prieto, Bruno Sangro & Rafael Aldabe. (2017) NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma. Oncotarget 8:25, pages 40967-40981.
Crossref
Crossref
David A. Alagpulinsa, Srinivas Ayyadevara, Shmuel Yaccoby & Robert J. Shmookler Reis. (2016) A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition. Molecular Cancer Therapeutics 15:2, pages 241-250.
Crossref
Crossref
Sujoy Bhattacharya, Ramesh M. Ray & Leonard R. Johnson. (2013) Cyclin-dependent kinases regulate apoptosis of intestinal epithelial cells. Apoptosis 19:3, pages 451-466.
Crossref
Crossref
Richard O. Adeyemi & David J. Pintel. (2014) Parvovirus-Induced Depletion of Cyclin B1 Prevents Mitotic Entry of Infected Cells. PLoS Pathogens 10:1, pages e1003891.
Crossref
Crossref
Erik S. Knudsen, Ryan J. Bourgo, Elizabeth L. Gosnell, Jeffry L. Dean & A. Kathleen McClendon. 2015. Molecular Oncology. Molecular Oncology
452
464
.
Qi Zheng, Ling-Yu Zhao, Ying Kong, Ke-Jun Nan, Yu Yao & Zi-Jun Liao. (2013) CDK-associated Cullin 1 can promote cell proliferation and inhibit cisplatin-induced apoptosis in the AGS gastric cancer cell line. World Journal of Surgical Oncology 11:1.
Crossref
Crossref
Jonathan L. Blank, Xiaozhen J. Liu, Katherine Cosmopoulos, David C. Bouck, Khristofer Garcia, Hugues Bernard, Olga Tayber, Greg Hather, Ray Liu, Usha Narayanan, Michael A. Milhollen & Eric S. Lightcap. (2013) Novel DNA Damage Checkpoints Mediating Cell Death Induced by the NEDD8-Activating Enzyme Inhibitor MLN4924. Cancer Research 73:1, pages 225-234.
Crossref
Crossref
Anamika Dhyani, Adriana S.S. Duarte, João A. Machado-Neto, Patricia Favaro, Manoela Marques Ortega & Sara T. Olalla Saad. (2012) ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells. FEBS Letters 586:24, pages 4311-4318.
Crossref
Crossref
Tapati Mazumdar, Jennifer DeVecchio, Akwasi Agyeman, Ting Shi & Janet A. Houghton. (2011) The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer. Oncotarget 2:8, pages 638-645.
Crossref
Crossref
Yaohui Wang, Yuchan Wang, Yan Xu, Wenyan Tong, TingTing Pan, Jianhua Li, Shuhui Sun, Junjie Shao, Huanping Ding, Tetsuya Toyoda & Zhenghong Yuan. (2011) Hepatitis C Virus NS5B Protein Delays S Phase Progression in Human Hepatocyte-derived Cells by Relocalizing Cyclin-dependent Kinase 2-interacting Protein (CINP). Journal of Biological Chemistry 286:30, pages 26603-26615.
Crossref
Crossref
Irina Neganova, Felipe Vilella, Stuart P. Atkinson, Maria Lloret, João F. Passos, Thomas von Zglinicki, José-Enrique O'Connor, Deborah Burks, Richard Jones, Lyle Armstrong & Majlinda Lako. (2011) An Important Role for CDK2 in G1 to S Checkpoint Activation and DNA Damage Response in Human Embryonic Stem Cells. Stem Cells 29:4, pages 651-659.
Crossref
Crossref
Han Liu, Yi-qing Liu, Yong-qing Liu, Ai-hui Xu, Charles Y.F. Young, Hui-qing Yuan & Hong-xiang Lou. (2010) A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells. Chemico-Biological Interactions 188:3, pages 598-606.
Crossref
Crossref
Bea Pauwels, An Wouters, Marc Peeters, Jan B Vermorken & Filip Lardon. (2010) Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation. Future Oncology 6:9, pages 1485-1496.
Crossref
Crossref
Addolorata Pisconti, D.D.W. Cornelison, Hugo C. Olguín, Tiffany L. Antwine & Bradley B. Olwin. (2010) Syndecan-3 and Notch cooperate in regulating adult myogenesis. Journal of Cell Biology 190:3, pages 427-441.
Crossref
Crossref
Luciana E. Giono & James J. Manfredi. 2010. Signal Transduction: Pathways, Mechanisms and Diseases. Signal Transduction: Pathways, Mechanisms and Diseases
375
395
.
Haiying Zhang, Zhan Xiao & Tom Sowin. 2009. Checkpoint Controls and Targets in Cancer Therapy. Checkpoint Controls and Targets in Cancer Therapy
245
259
.
Neil Johnson & Geoffrey I. Shapiro. 2010. Cell Cycle Deregulation in Cancer. Cell Cycle Deregulation in Cancer
167
185
.
Claudia E. Rübe, Saskia Grudzenski, Martin Kühne, Xiaorong Dong, Nicole Rief, Markus Löbrich & Christian Rübe. (2008) DNA Double-Strand Break Repair of Blood Lymphocytes and Normal Tissues Analysed in a Preclinical Mouse Model: Implications for Radiosensitivity Testing. Clinical Cancer Research 14:20, pages 6546-6555.
Crossref
Crossref
Chit Fang Cheok, Anwesha Dey & David P. Lane. (2007) Cyclin-Dependent Kinase Inhibitors Sensitize Tumor Cells to Nutlin-Induced Apoptosis: a Potent Drug Combination. Molecular Cancer Research 5:11, pages 1133-1145.
Crossref
Crossref
Ulka Vijapurkar, Wei Wang & Ronald Herbst. (2007) Potentiation of Kinesin Spindle Protein Inhibitor–Induced Cell Death by Modulation of Mitochondrial and Death Receptor Apoptotic Pathways. Cancer Research 67:1, pages 237-245.
Crossref
Crossref
John Hunt. 2006. Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents. Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents
251
264
.
Luciana E. Giono & James J. Manfredi. (2006) The p53 tumor suppressor participates in multiple cell cycle checkpoints. Journal of Cellular Physiology 209:1, pages 13-20.
Crossref
Crossref
Dongpo Cai, Vaughan M. LathamJr.Jr., Xinxin Zhang & Geoffrey I. Shapiro. (2006) Combined Depletion of Cell Cycle and Transcriptional Cyclin-Dependent Kinase Activities Induces Apoptosis in Cancer Cells. Cancer Research 66:18, pages 9270-9280.
Crossref
Crossref
Andrew J. Deans, Kum Kum Khanna, Carolyn J. McNees, Ciro Mercurio, Jörg Heierhorst & Grant A. McArthur. (2006) Cyclin-Dependent Kinase 2 Functions in Normal DNA Repair and Is a Therapeutic Target in BRCA1-Deficient Cancers. Cancer Research 66:16, pages 8219-8226.
Crossref
Crossref
Judit Ribas, Jacint Boix & Laurent Meijer. (2006) (R)-Roscovitine (CYC202, Seliciclib) sensitizes SH-SY5Y neuroblastoma cells to nutlin-3-induced apoptosis. Experimental Cell Research 312:12, pages 2394-2400.
Crossref
Crossref
Marc Payton, Grace Chung, Peter Yakowec, Andrew Wong, Dave Powers, Ling Xiong, Nancy Zhang, Juan Leal, Tammy L. Bush, Vincent Santora, Ben Askew, Andrew Tasker, Robert Radinsky, Richard Kendall & Steve Coats. (2006) Discovery and Evaluation of Dual CDK1 and CDK2 Inhibitors. Cancer Research 66:8, pages 4299-4308.
Crossref
Crossref
Greg H. Enders & Shannon L. Maude. (2006) Traffic safety for the cell: Influence of cyclin-dependent kinase activity on genomic stability. Gene 371:1, pages 1-6.
Crossref
Crossref
Tetsuya Tsukamoto, Hiroki Sakai, Akihiro Hirata, Hiroko Fukami & Masae Tatematsu. (2006) Three-dimensional analysis of isolated hexosaminidase-altered aberrant crypts from colons of 1,2-dimethylhydrazine-treated rats. Experimental and Toxicologic Pathology 57:4, pages 283-289.
Crossref
Crossref
Shannon L. Maude & Greg H. Enders. (2005) Cdk Inhibition in Human Cells Compromises Chk1 Function and Activates a DNA Damage Response. Cancer Research 65:3, pages 780-786.
Crossref
Crossref
Tetsuya Tsukamoto, Akihiro Hirata & Masae Tatematsu. (2005) Susceptibility of Heterozygous and Nullizygous p53 Knockout Mice to Chemical Carcinogens: Tissue Dependence and Role of p53 Gene Mutations. Journal of Toxicologic Pathology 18:3, pages 121-134.
Crossref
Crossref